Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Vertical Transmission of Hepatitis C Virus Subtype 1a in HCV/HIV Coinfected Patient: A Case Report

Abdul Waheed Khan, Fazli Zahir, Zeeshan Nasim, Muhammad Adil Khan, Muhammad Abdullah, Abdul Haleem Khan and Ismail Khan

Introduction: Vertical transmission of Hepatitis C Virus (HCV) is not commonly reported in literature. Although rare, it is one of the leading causes of HCV infection in early childhood. Coinfection of HCV with Human Immune Deficiency Virus (HIV) has been frequently associated with enhanced vertical transmission of HCV. Case presentation: We present the case of a lady found positive for HCV/HIV coinfection, who delivered a male infant retaining HCV infection. Detailed examination of the infant revealed the possible acquisition of HCV from the infected mother. During the prolonged follow up session of 22 months, laboratory reports of the infant indicated signs of persistant HCV infection.
Conclusion: The study highlights the vertical transmission of HCV subtype 1a in HCV/HIV coinfected patient. It emphasize the consideration of effective management guidelines such as pre-conception anti- HCV screening for better treatment possibilities and the need of effective treatment regimens for prospective mothers during pregnancy to minimize the chances of HCV transmission to expected child.